Cargando…

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer

Head and neck squamous cell carcinomas (HNSCC) affect more than 800,000 people annually worldwide, causing over 15,000 deaths in the US. Among HNSCC cancers, human papillomavirus (HPV)-negative HNSCC has the worst outcome, motivating efforts to improve therapy for this disease. The most common mutat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deneka, Alexander Y., Einarson, Margret B., Bennett, John, Nikonova, Anna S., Elmekawy, Mohamed, Zhou, Yan, Lee, Jong Woo, Burtness, Barbara A., Golemis, Erica A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072436/ https://www.ncbi.nlm.nih.gov/pubmed/32012873 http://dx.doi.org/10.3390/cancers12020306

Ejemplares similares

Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015)

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
por: Gaponova, Anna V., et al.
Publicado: (2016)

NEDD9 sustains hexokinase expression to promote glycolysis
por: Deneka, Alexander Y., et al.
Publicado: (2022)

Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
por: Deneka, Alexander Y., et al.
Publicado: (2017)

Genomic insights into head and neck cancer
por: Beck, Tim N., et al.
Publicado: (2016)

Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease
por: Nikonova, Anna S., et al.
Publicado: (2015)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

The Antiviral Agent Cidofovir Induces DNA Damage and Mitotic Catastrophe in HPV-Positive and -Negative Head and Neck Squamous Cell Carcinomas In Vitro
por: Verhees, Femke, et al.
Publicado: (2019)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Microscopy-Based Automated Live Cell Screening for Small Molecules That Affect Ciliation
por: Zhang, Peishan, et al.
Publicado: (2019)

Novel Molecular Targets for Chemoprevention in Malignancies of the Head and Neck
por: Bhatia, Aarti, et al.
Publicado: (2017)

Introducing cancers of the head and neck, a new open access journal
por: Burtness, Barbara
Publicado: (2016)

Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization
por: Ramirez, Ursula D., et al.
Publicado: (2015)

Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
por: Lim, Yenkai, et al.
Publicado: (2016)

Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers
por: Dok, Rüveyda, et al.
Publicado: (2021)

Hypoxia and Its Influence on Radiotherapy Response of HPV-Positive and HPV-Negative Head and Neck Cancer
por: Wegge, Marilyn, et al.
Publicado: (2021)

NF-κB over-activation portends improved outcomes in HPV-associated head and neck cancer
por: Schrank, Travis P., et al.
Publicado: (2022)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients
por: Wan, Yunxia, et al.
Publicado: (2017)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

Mechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
por: Griso, Ana Belén, et al.
Publicado: (2022)

Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer
por: Wang, Zhongqiu, et al.
Publicado: (2023)

Deciphering the Tumor–Immune–Microbe Interactions in HPV-Negative Head and Neck Cancer
por: Hu, Min, et al.
Publicado: (2023)

Biomarker driven treatment of head and neck squamous cell cancer
por: Eze, Nnamdi, et al.
Publicado: (2017)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
por: Stögbauer, Fabian, et al.
Publicado: (2023)

HPV Associated Head and Neck Cancer
por: Spence, Tara, et al.
Publicado: (2016)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
por: Li, Shuangying, et al.
Publicado: (2022)

Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer
por: Al-Soneidar, Walid A., et al.
Publicado: (2022)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
por: Benavente, Sergi
Publicado: (2023)

Intrinsic Radiosensitivity Is Not the Determining Factor in Treatment Response Differences between HPV Negative and HPV Positive Head and Neck Cancers
por: Reid, Paul, et al.
Publicado: (2020)

The DNA Damage Response Is Differentially Involved in HPV-Positive and HPV-Negative Radioresistant Head and Neck Squamous Cell Carcinoma
por: Bamps, Marieke, et al.
Publicado: (2021)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
por: Chantre-Justino, Mariana, et al.
Publicado: (2022)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
por: Du, Eric Y., et al.
Publicado: (2022)

Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition
por: Shen, John Paul, et al.
Publicado: (2015)

A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
por: Pathak, Harsh B., et al.
Publicado: (2015)

Special Issue “HPV in the Head and Neck Region”
por: Dalianis, Tina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0n7d6t7852sa4ehcm31lpk7n05